Streetbeat News

Analyst Ratings

CVE

Cenovus Energy reported Q2 earnings of $0.33 per share, beating the analyst consensus estimate of $0.31 by 6.45%. However, the company's quarterly sales of $9.11 billion missed the analyst consensus estimate of $9.76 billion by 6.71%. This represents a 64.52% decrease in earnings and a 39.37% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:20 am

MAG

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on MAG Silver and raises the price target from C$16 to C$20.5.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:17 am

AVNT

Avient (NYSE:AVNT) reported Q2 earnings of $0.63 per share, beating the analyst consensus estimate of $0.60 by 5%. However, this is a 35.71% decrease from the same period last year. The company's quarterly sales were $824.40 million, missing the analyst consensus estimate of $842.97 million by 2.20%, and a 7.47% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 10:16 am

MWRK

HC Wainwright & Co. analyst Kevin Dede has initiated coverage on MetaWorks Platforms with a Neutral rating.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:16 am

SMURF

HC Wainwright & Co. analyst Kevin Dede has initiated coverage on Tokens.com (OTC:SMURF) with a Neutral rating.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:14 am

VRCA

HC Wainwright & Co. analyst Oren Livnat maintains a 'Buy' rating on Verrica Pharmaceuticals (NASDAQ:VRCA) and raises the price target from $11 to $12.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:12 am

ALKS

HC Wainwright & Co. analyst Douglas Tsao has reiterated a Neutral rating on Alkermes (NASDAQ:ALKS) and maintained a $34 price target.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:12 am

AMLX

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Amylyx Pharma (NASDAQ:AMLX) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:10 am

NOW

Needham analyst Jack Andrews has reiterated a 'Buy' rating on ServiceNow (NYSE:NOW) and maintained a price target of $660.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 10:09 am